🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Gram(s) Serving Size
84 Servings
Other Combinations Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

L. Acidophilus
L. Bulgaricus
FOS
100 mg
📊 Market median: 100.0mg (1 products) 📚 42 studies (Tier A: 1, B: 15)
This product: 100mg

Other Ingredients

Vegetable Cellulose

Label Claims — Verification

Nutrient
All Other
All Other (99% of products) Structure/Function (91% of products) Nutrient (14% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take 1/4 of a teaspoon (1 g) daily, preferably with water, or as directed by a healthcare practitioner.

🧪 Formulation Notes

Specially formulated with lactobacillus acidophilus, lactobacillus bulgaricus, bifidobacterium bifidum and FOS (fructooligosaccharides).

Made with non GMO ingredients

L. Acidophilus, L. Bulgaricus, Bifidum

Free of milk, egg, fish, crustacean shellfish, tree nuts, peanuts, wheat and soybeans. Also free of yeast, gluten, barley, rice and sodium.

Additional Information

Bluebonnet’s Milk-Free-Probiotic Acidophilus Plus FOS Powder contains over ten billion viable microorganisms per gram.

FOS is a unique carbohydrate from chicory root extract. Designed to help promote the growth of friendly bacteria in the gastrointestinal tract.

0915D

Made with non GMO ingredients

Gluten free

Refrigeration required.

Product Details

UPC / SKU 7 43715 00915 8
DSLD Entry Date 2018-07-25
Product Type Other Combinations
Form Powder
Brand Bluebonnet
DSLD ID 178947
Data Updated 2026-04-11

Research Evidence

691 Research Sources
52 Avg Quality Score
255 Clinical Trial
205 Meta Analysis
123 Rct
81 Systematic Review
18 Cochrane Review
2 Guideline
2 Regulatory Source
1 Other
1 Narrative Review
1 Openfda Safety
A Probiotics for preventing acute upper respiratory tract infections
Systematic Review The Cochrane database of systematic reviews 2022
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2015
A Probiotics for maintenance of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020
A Probiotics for induction of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2011
A Probiotics for treating eczema
Meta Analysis The Cochrane database of systematic reviews 2018
A Probiotics for treating acute infectious diarrhoea
Meta Analysis The Cochrane database of systematic reviews 2020
A The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies
Systematic Review International journal of molecular sciences 2022
A Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Meta Analysis The Cochrane database of systematic reviews 2017
A Probiotics to prevent infantile colic
Meta Analysis The Cochrane database of systematic reviews 2019
View all evidence for Probiotics →

Compare Similar Products

View all Probiotics products →